Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development (Q35191379)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development (English)

1 reference

Europe PubMed Central

7 August 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Meriones unguiculatus

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Tatsuo Yamamoto

1

object named as

Tatsuo Yamamoto

1 reference

Europe PubMed Central

7 August 2017

3

object named as

Wataru Higuchi

1 reference

Europe PubMed Central

7 August 2017

2

object named as

Tomomi Takano

1 reference

Europe PubMed Central

7 August 2017

author name string

Akihito Nishiyama

4

1 reference

Europe PubMed Central

7 August 2017

Ikue Taneike

5

1 reference

Europe PubMed Central

7 August 2017

Kumi Yoshida

6

1 reference

Europe PubMed Central

7 August 2017

Hiroko Kanda

7

1 reference

Europe PubMed Central

7 August 2017

Yuichiro Imamura

8

1 reference

Europe PubMed Central

7 August 2017

language of work or name

0 references

publication date

5 July 2011

1 reference

Europe PubMed Central

7 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

7 August 2017

55

1 reference

Europe PubMed Central

7 August 2017

9

1 reference

Europe PubMed Central

7 August 2017

4261-4266

1 reference

Europe PubMed Central

7 August 2017

Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

In vitro susceptibility to antimicrobial agents and ultrastructural characteristics related to swimming motility and drug action in Campylobacter jejuni and C. coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Host-bacterial interactions in Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Eradication therapy for Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Extragastric diseases associated with Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Fast and Accurate Quantitative Detection of Helicobacter pylori and Identification of Clarithromycin Resistance Mutations in H . pylori Isolates from Gastric Biopsy Specimens by Real-Time PCR

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

13 July 2018

The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

27 September 2018

Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

27 September 2018

In vitro and in vivo anti- Helicobacter pylori activity of Y-904, a new fluoroquinolone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165289

27 September 2018

Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease by use of a short-term Mongolian gerbil infection model

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy, antagonism, and what the chequerboard puts between them

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination antifungal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amoxycillin tolerance in Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21730117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.01105-10

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35191379&oldid=2143734052"